HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 295/2/C350    most recent 00224.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Green, H. J. Articles by Ouyang, J. Search for Related Content PubMed PubMed Citation Articles by Green, H. J. Articles by Ouyang, J.

MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS

Abnormal sarcoplasmic reticulum Ca²⁺-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease

¹Department of Kinesiology, University of Waterloo, Waterloo, Ontario; and ²Division of Respiratory and Critical Care Medicine, Department of Medicine, Queen's University, Kingston, Ontario, Canada

Submitted 24 April 2008 ; accepted in final form 24 May 2008

The objective of this study was to investigate the hypothesis that alterations in sarcoplasmic reticulum (SR) Ca²⁺-cycling properties would occur in skeletal muscle in patients with moderate to severe chronic obstructive pulmonary disease (COPD). To investigate this hypothesis, tissue samples were obtained from the vastus lateralis of 8 patients with COPD [age 65.6 ± 3.2 yr; forced expiratory volume in 1 s (FEV₁)/forced vital capacity (FVC) = 44 ± 2%; mean ± SE] and 10 healthy age-matched controls (CON, age 67.5 ± 2.5 yr; FEV₁/FVC = 77 ± 2%), and homogenates were analyzed for a wide range of SR properties. Compared with CON, COPD displayed (in µmol·g protein^–1·min^–1) a 16% lower maximal Ca²⁺-ATPase activity [maximal velocity (V_max), 158 ± 10 vs. 133 ± 7, P < 0.05] and a 17% lower Ca²⁺ uptake (4.65 ± 0.039 vs. 3.85 ± 0.26, P < 0.05) that occurred in the absence of differences in Ca²⁺ release. The lower V_max in COPD was also accompanied by an 11% lower (P < 0.05) Ca²⁺ sensitivity, as measured by the Hill coefficient (defined as the relationship between Ca²⁺-ATPase activity and free cytosolic Ca²⁺ concentration for 10–90% V_max). For the sarco(endo)plasmic reticulum Ca²⁺-ATPase (SERCA) isoforms, SERCA1a was 16% higher (P < 0.05) and SERCA2a was 14% lower (P < 0.05) in COPD. It is concluded that moderate to severe COPD results in abnormalities in SR Ca²⁺-ATPase properties that cannot be explained by changes in the SERCA isoform phenotypes. The reduced catalytic properties of SERCA in COPD suggest a disturbance in Ca²⁺ cycling, possibly resulting in impairment in Ca²⁺-mediated mechanical function and/or second messenger regulated processes.

skeletal muscle; lung disease; sarcoplasmic reticulum; calcium regulation

This article has been cited by other articles:

				A. Ogawa, A. L. Firth, W. Yao, M. M. Madani, K. M. Kerr, W. R. Auger, S. W. Jamieson, P. A. Thistlethwaite, and J. X.-J. Yuan Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L666 - L676. [Abstract] [Full Text] [PDF]

				M.-A. Caron, R. Debigare, P. N. R. Dekhuijzen, and F. Maltais Comparative assessment of the quadriceps and the diaphragm in patients with COPD J Appl Physiol, September 1, 2009; 107(3): 952 - 961. [Abstract] [Full Text] [PDF]

				H. J. Green, M. E. Burnett, C. L. D'Arsigny, D. E. O'Donnell, J. Ouyang, and K. A. Webb Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease J Appl Physiol, September 1, 2008; 105(3): 879 - 886. [Abstract] [Full Text] [PDF]

				D. O'Donnell and K. Webb Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation J Appl Physiol, August 1, 2008; 105(2): 765 - 765. [Full Text] [PDF]